- Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.
- The lawsuit filed in federal district court in New Jersey argues the Medicare negotiations violate the First and Fifth Amendments of the U.S. Constitution.
- Earlier suits brought separately by Merck and Bristol Myers Squibb, as well as by the U.S. Chamber of Commerce and PhRMA, the pharmaceutical industry’s largest lobbying group, made similar arguments.

-
read more at cnbc.com
previous articleEU Sends Water Bombers To Battle Greece Wildfires As Rome Shatters Temperature Record
next articleEU Sends Water Bombers To Battle Greece Wildfires As Rome Shatters Temperature Record